ATE502636T1 - Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen - Google Patents

Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen

Info

Publication number
ATE502636T1
ATE502636T1 AT04790183T AT04790183T ATE502636T1 AT E502636 T1 ATE502636 T1 AT E502636T1 AT 04790183 T AT04790183 T AT 04790183T AT 04790183 T AT04790183 T AT 04790183T AT E502636 T1 ATE502636 T1 AT E502636T1
Authority
AT
Austria
Prior art keywords
topical compositions
dermatological diseases
telmestein
treatment
dermatitis
Prior art date
Application number
AT04790183T
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE502636T1 publication Critical patent/ATE502636T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT04790183T 2003-10-09 2004-10-07 Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen ATE502636T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001941A ITMI20031941A1 (it) 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PCT/EP2004/011228 WO2005037275A1 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders

Publications (1)

Publication Number Publication Date
ATE502636T1 true ATE502636T1 (de) 2011-04-15

Family

ID=34452248

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04790183T ATE502636T1 (de) 2003-10-09 2004-10-07 Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen

Country Status (11)

Country Link
US (2) US20070213381A1 (de)
EP (1) EP1670464B1 (de)
JP (1) JP2007508264A (de)
CN (1) CN1863529A (de)
AT (1) ATE502636T1 (de)
AU (2) AU2004281521B2 (de)
BR (1) BRPI0415225A (de)
CA (1) CA2540859A1 (de)
DE (1) DE602004031964D1 (de)
IT (1) ITMI20031941A1 (de)
WO (1) WO2005037275A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471135A (en) * 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
EP2641906B1 (de) * 2009-07-08 2015-04-22 Dermira (Canada), Inc. Tofa-Analoga zur Behandlung von Hauterkrankungen oder -Störungen
US20120109042A1 (en) * 2010-10-28 2012-05-03 John Koo Methods of Treating Diseased Tissue
KR101670765B1 (ko) * 2014-09-19 2016-11-01 주식회사 명진뉴텍 글리신계 물질을 포함하는 방부조성물
ES2834905T3 (es) 2017-06-27 2021-06-21 Daxxin AB Composición líquida para lavar el cuero cabelludo y el cabello, o para lavar la piel que comprende piroctona olamina
EP3644951A1 (de) 2017-06-30 2020-05-06 The Procter and Gamble Company Haarpflegezusammensetzung mit einem 2-pyridinol-n-oxidmaterial und einem eisenchelatbildner
US10543164B2 (en) 2017-06-30 2020-01-28 The Procter & Gamble Company Deodorant compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869772D1 (de) 1988-06-29 1992-05-07 Yason S.R.L., Mailand/Milano, It
WO1995000136A1 (en) * 1993-06-18 1995-01-05 Arcturus Pharmaceutical Corporation Method for treating hyperkeratosis and diseases mediated by proteases
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Also Published As

Publication number Publication date
EP1670464A1 (de) 2006-06-21
AU2004281521A1 (en) 2005-04-28
DE602004031964D1 (de) 2011-05-05
EP1670464B1 (de) 2011-03-23
CA2540859A1 (en) 2005-04-28
AU2008203101A1 (en) 2008-08-07
US20070213381A1 (en) 2007-09-13
US20100130568A1 (en) 2010-05-27
JP2007508264A (ja) 2007-04-05
BRPI0415225A (pt) 2006-12-05
AU2004281521B2 (en) 2008-04-17
CN1863529A (zh) 2006-11-15
WO2005037275A1 (en) 2005-04-28
US8431601B2 (en) 2013-04-30
ITMI20031941A1 (it) 2005-04-10

Similar Documents

Publication Publication Date Title
DE60325379D1 (de) Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen
DE60136348D1 (de) Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
MX344787B (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
RU2014150505A (ru) Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DE60231050D1 (de) Verwendung von Totarol zur Behandlung von Pruritus
DK1893237T3 (da) Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof
ATE502636T1 (de) Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen
TW200517137A (en) Method for decreasing sebum production
MXPA05010416A (es) Combinacion de substancias activas de aceites minerales que contienen acidos grasos (3 con extractos vegetales que contengan polifenoles y su uso.
DK1343472T3 (da) Thixotropisk næsespray
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
ATE516028T1 (de) Zusammensetzung zur behandlung von hauterkrankungen
JP2016501236A5 (de)
DE10347487A1 (de) Kosmetische oder dermatologische Zusammensetzung zur topischen Verwendung
US9757326B2 (en) Hair rejuvenating lotion
WO2009036751A3 (de) Kosmetische oder dermatologische zusammensetzung zur topischen verwendung
DK1620116T3 (da) Anvendelse af cinchona til fremstilling af et l gemiddel, som stimulerer angiogenese

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties